 (N Engl J Med 1998;338:1181-5) 
The explosion in interest in lung volume reduction since these patients present with the worst symptoms at a relatively young age. surgery (LVRS) is well demonstrated by the number of operations being carried out and the number of The report by Cassina et al 3 is at first sight encouraging with similar three month benefits for 1 E and SE and publications claiming benefit.
1 This traditional way of accumulating and sharing surgical experience is valuable therefore argues against the usual advice that those with lower zone emphysema do worse. The difference but inevitably provides distorted evidence. In the first place there is unavoidable publication bias; poor results between the two groups in the durability of benefit is perhaps less striking than the abstract implies. Certainly and high mortality are unlikely to be written up and unlikely to be published. Secondly, all series of opforced expiratory volume in one second (FEV 1 ), total lung capacity (TLC), and residual volume (RV) declined erations are performed on highly selected patients with individual surgeons using personal selection criteria faster in the 1 E group from three to 12 months but thereafter the slopes were parallel. In contrast, the dewhich may differ between centres. In particular, the likely inclusion of patients with classical bullae in some cline in dyspnoea score, six minute walking distance, and diaphragmatic pressure were similar for both groups. series may greatly overvalue the benefits of the operation.
The results are therefore difficult to compare and imFurthermore, patients with 1 E lose FEV 1 and lung volumes more rapidly even without LVRS and so the possible to apply to wider groups of patients. Thirdly, there are no controlled studies and so evaluation of long reported decline cannot be attributed to the operation alone. Clearly, any statement about long term decline term results against the expected long term decline in unoperated patients involves imagination and guesswould be strengthened by the inclusion of an unoperated control group. work.
Against this background all reports of selection criteria Taken together these reports make a valuable contribution to the LVRS debate, but also emphasise the and long term results are welcome but must be evaluated cautiously. • Does LVRS really work? a prospective way. Multiple linear regression analysis is good at finding correlations within a particular series
• If it works, how, who and when?
• Is it worth it? but often the finding cannot be confirmed in another group. Secondly, hidden selection criteria before entry into the study may be very important. Although the patients in this study were chosen in the usual way from Does LVRS really work?
The review by Russi et al in 1997 8 listed 10 reports on ex-smokers with emphysema and flattened diaphragms, this still leaves plenty of room for physician judgement a total of 958 patients who had had LVRS. Improvements in FEV 1 ranged from 13% (VATS with laser) to of suitability according to clinical, lung function, and computed tomographic (CT) findings. Most centres an astonishing 82%. 6 Since then there have been at least 16 more reports on over 800 further patients (the exact find that they exclude up to 80% of referrals so the value of ILR or any other test may apply only to a subset number is unclear due to duplicate reporting) with similar changes. The reported changes following LVRS of 20%. Thirdly, there are some technical curiosities in the data: static compliance of 0.25 l/cm H 2 O is low for are summarised in table 1. Most series have included preoperative rehabilitation severe emphysema but was measured over the range total lung capacity (TLC) -0.5 l to TLC. Similarly, which achieved some improvement in exercise tolerance but have shown further increase in walking distance the control ILR of 1.0 cm H 2 O/l/s is rather low. While these points do not invalidate the conclusions, they after LVRS, usually in line with improvement in FEV 1 .
When measured, quality of life usually shows parallel emphasise the difficulties involved in processing oesophageal measurements. Finally, ILR is derived from improvements. These benefits are best at 3-6 months and the few studies which have included longer term four separate variables, each with technical problems, and few laboratories are familiar with oesophageal presmeasurements show either "sustained benefit at 1-2 sure measurements and their artefacts (heart beat, oesophageal contractions, etc). While these problems are not insurmountable, they certainly limit easy and early analysed such patients separately. 6 7 Nevertheless, the oxygen uptake; VEmax=maximum minute ventilation.
role of LVRS in 1 E is particularly important to define group.bmj.com on September 21, 2017 -Published by http://thorax.bmj.com/ Downloaded from years" or subsequent decline. There are not enough contribution of the diaphragm and other respiratory muscles is deranged and incoordinate. long term data to give a clear picture of what happens after two years. In any event, such long term data would All of these changes, with the exception of intrinsic airway narrowing, are potentially corrected by LVRS be difficult to judge without untreated controls. Deaths, operative complications, and longer term disadvantages and measures of each have been reported to improve. In particular, the static elastic recoil pressure increases are only inconsistently reported. Operative/short term mortality ranges from 0 to 17% 10 with one study rewith favourable effects on driving pressure, airway traction, and therefore expiratory flow rates. Volume reporting death in six of 16 patients in a subgroup with a combination of Pa 2 >45 mm Hg (6.0 kPa) and six duction moves ventilation to a more optimal part of the pressure/volume curve and a reduction in intrinsic PEEP minute walking distance less than 200 m. 11 There are a few reports of surgical units having bad results, parincreases dynamic compliance. In addition, recruitment of healthy lung units and correction of distorted airway ticularly in the first few operations, and it is very likely that selective reporting gives a falsely good picture.
geometry may also contribute. The above changes in rib cage shape and respiratory muscle function are all Inevitably, centres with greater experience become increasingly skilled at patient selection and perioperative to some degree reversed with consequent increase in diaphragmatic pressures and better coordination of the management, and mortality probably settles at around 5%. In this context it is salutary to remember that diaphragm and other respiratory muscles.
There have also been some reported improvements Brantigan's original operation in the 1950s never caught on because of an early mortality of around 16%.
in gas exchange with reduction in dead space ventilation, in haemodynamics with improvements in right ventThere is therefore a large body of evidence reporting benefit but, in spite of this, not everyone is convinced. ricular function and exercise pulmonary vascular resistance, and in measures of respiratory drive. All these Medicare has refused to fund LVRS in the absence of a controlled clinical trial and the American Thoracic changes are somewhat inconsistent and likely to be less important than the changes in lung mechanics and Society, among many other groups, has also called for better evidence.
12 13 Such controlled trials have been muscle function. The net effect of these improvements is better exercise performance which is chiefly reflected started and one UK trial will shortly be reported. Unfortunately they are notoriously difficult to conduct in an increase in tidal volume and ventilatory reserve with a reduction in dead space/tidal volume ratio. The since determined patients may shop around and many are reluctant to spend their declining years in an unconsequent reduction in work of breathing, both at rest and on exercise, then reduces the sensation of treated control group while reading newspaper reports of dramatic benefits. This is especially a problem in a breathlessness with favourable effects on exercise performance and quality of life. mixed health care system where money talks and surgeons are already convinced that the operation works.
While all these mechanisms are to some extent confounded by secondary adaptations and the relevant Patients allocated to the control arm are likely to pay for an operation privately.
measurements are subject to artefact leading to the sort of debate that is enjoyed by respiratory physiologists, the Meanwhile some surgeons remain unconvinced of the need for a controlled trial and consider the size and overall messages are clear. Firstly, the most important effects of LVRS are on elastic recoil and respiratory statistical significance of the changes after surgery as sufficient proof. Furthermore, Myers et al have commuscle function. Secondly, there is a complex interaction of effects such that non-responders to surgery pared 22 LVRS candidates denied surgery by Medicare with 65 "contemporaneous and comparable" LVRS show the same preoperative functional changes as responders. Thirdly, no single preoperative measure is yet recipients.
14 The surgical group showed sustained improvement and 82% survival while those denied surgery accepted as a good preoperative predictor of benefit. The report on ILR by Ingenito et al 2 should be seen in lost lung function and had 64% survival.
So, does it really work? Of course it does, but only this context, but we are still far from defining precisely who will benefit from surgery and when to do it. for the right person at the right time in the right place. Perhaps if we know how it works we will be better at answering the questions who and when.
LVRS: who and when? Most groups have selected or excluded patients according to the criteria in table 2. These are clinically
How does LVRS work?
In emphysema destruction and distension of alveoli lead to a loss of elastic recoil which itself results in a lower fibres is mechanically inefficient; and finally, the relative group.bmj.com on September 21, 2017 -Published by http://thorax.bmj.com/ Downloaded from sensible selection criteria intended to minimise risk and carrying out LVRS should be encouraged to perform full functional assessments before surgery and to continue to maximise the chances of benefit but none has been formally tested. LVRS centres have turned down 50-search for correlations with success and failure. Although there has been much discussion and many 80% of early referrals reflecting, on the one hand, relative lack of experience among referrers and, on the publications about selection criteria in terms of severity and distribution of emphysema, little attention has been other, desperation and willingness to clutch at straws among patients with high levels of symptoms. In spite focused on timing. Lung function deteriorates with age in non-smokers and faster in smokers and the optimal of this selection, mortality still ranges from 4% to 17%. 10 Operative risk is naturally higher when experience is moment for LVRS is unknown. Furthermore, operative risk inevitably increases with both age and deteriorating limited and the severity of the underlying disease is worse. Szekely et al 11 reported unacceptable mortality lung function. If surgery is proposed relatively early the risks will be lower but there may not be enough to gain. with low walking distance and high Pa 2 , and our own experience would confirm this together with an Conversely, to wait until symptoms and disability are severe may subject the patient to an unacceptable risk. increased risk with low carbon monoxide transfer factor (T). In contrast, Eugene et al reported good out-
The decision is further complicated by the facts that lung function correlates poorly with symptoms and there comes among 41 patients with FEV 1 <500 ml, 80% of whom were oxygen dependent and hypercapnic. 15 This is an interaction between personality and psychological state, on the one hand, and the level of symptoms for suggests that with increasing experience the risk falls even among the most severely affected patients. At a given functional impairment on the other. People with emphysema tend to become frustrated by their present there is insufficient evidence to give clear cut exclusion criteria based on lung function measurements immobility and depression and resentment can be a consequence. Such people shout the loudest for an or mobility.
Only 50-75% of patients improve with surgery so operation but are the ones who will be most damaged by a poor result. Conversely, the stoic who copes well reliable predictors of benefit are badly needed. Clearly, the more patchy the disease the easier it is for the with disability may be an ideal candidate for surgery but never comes forward because he doesn't complain surgeon to select target areas for volume reduction and the greater the chance of reclaiming function from enough. Smoking cessation, weight reduction, and preoperative rehabilitation are all valuable in improving the surrounding compressed lung. The extreme example of this is the large isolated bulla and bullectomy has been patient's mobility before a decision on surgery is taken. The delay also allows some estimate of the rate of decline well established as an effective treatment for many years, particularly when there is evidence of compressed lung of lung function. Improved weight and symptoms with no evidence of functional decline persuades many on CT scanning together with good lung function elsewhere. Zonal distribution is similarly important and the patients and their physicians to leave well alone. Finally, no one knows whether LVRS is good or bad in the Zurich 16 and St Louis 17 groups have shown better results with upper than with lower zone predominant emlonger term. This is important for younger patients with dependants who want to know about the benefits and physema, although this finding may be confounded by the greater heterogeneity and better function of the risks over 20 years. Clearly, we do not know all the answers and it will take a long time to find out. Everyone remaining lung that tends to go with upper zone predominance. There is now reasonable evidence that CT in the field has a responsibility to keep good records and ensure long term follow up so that we get the scanning is as good as any other imaging technique in assessing heterogeneity and distribution and neither answers quickly. ventilation/perfusion scanning nor magnetic resonance imaging have shown any worthwhile advantages. In spite of these arguments there is accumulating evidence that Is it worth it? There are two ways of looking at the cost/benefit ratiohomogeneous disease without any obvious target areas for resection can also improve with volume reduction clinical and health economic. The clinical debate ranges from enthusiasts recounting their best clinical anecdote and it is in this group that preoperative functional measurement predicting success is likely to be the most to detractors remembering the deaths and prolonged morbidity in those who do not improve. The resolution valuable. If the main mechanisms involved are alteration in elastic recoil and diaphragmatic configuration, it is of these arguments must lie in improved patient selection so that non-responders are spared the operation and logical to propose that preoperative assessment should focus on simple associated variables such as diasuccess rates increase. We must of course wait for the much longer term results before the clinical cost/benefit phragmatic shape and pressure generation. All centres LEARNING POINTS * LVRS is of benefit to some but not all patients. * Patient selection is crucial but further refinement of the selection criteria is required. * The timing of LVRS in the natural history of the disease is important. * Current surgical series describe benefit from LVRS but controlled trials are required. These will be difficult to carry out. * LVRS should be done in a small number of specialised centres with the necessary expertise, treating sufficient numbers of patients to answer outstanding questions regarding the technique.
analysis is complete. The health economic arguments thousands of people with emphysema LVRS could make as much difference to them as coronary artery surgery are more complex. LVRS is expensive and potential does for those with ischaemic heart disease. The two candidates are elderly and numerous. As a result funders operations have a similar evidence base and should be are asking for health economic evaluation and better given similar priority. proof before signing any cheques. Hospital costs depend upon the length of stay and range in the USA from 
